Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by DoseMe

DoseMe Acquires Firstline to Build End-to-End Clinical Decision Support for Health Systems in the Global Fight Against Infectious Disease
From DoseMe
Via Business Wire
Senior Care Partners (PACE) Advances Elderly Patient Safety with DoseMeRx
From DoseMe
Via Business Wire
University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx
From DoseMe
Via Business Wire
DoseMe Expands Licensing Agreement with Dot.lib
From DoseMe
Via Business Wire
DoseMe Achieves HITRUST Risk-Based, 2-year (r2) Certification
From DoseMe
Via Business Wire
DoseMe Enhances Web-based User Experience and Capability to Further Scale its Precision Dosing Platform
From DoseMe
Via Business Wire
DoseMeRx Submitted a Formal Application for CE Certification Under MDR, Ensuring Uninterrupted Service and Safety for Customers and Patients
From DoseMe
Via Business Wire
Dameron Hospital Selects DoseMeRx to Advance Precision Dosing
From DoseMe
Via Business Wire
DoseMe Enables Precision Dosing at Independence Health System
From DoseMe
Via Business Wire
DoseMe Expands Global Footprint as Premier Hospitals and Cancer Centers across Australia Continue to Adopt Bayesian Dosing
From DoseMe
Via Business Wire
Media Advisory: DoseMe Bioinformatician and Chief Science and Strategy Officer Co-Author Abstract Big Data Bayesian Truths to Be Covered in Oral Presentation at the 24th ECCMID Annual Meeting
From DoseMe
Via Business Wire
Advanced Infliximab Model Now Available from DoseMe
From DoseMe
Via Business Wire
DoseMe Partners with Albertina icome Praha as Demand for Precision Dosing in Czech and Slovakia Continues to Increase
From DoseMe
Via Business Wire
DoseMe Expands Vancomycin Hemodialysis Model
From DoseMe
Via Business Wire
DoseMe Expands Its Reseller Agreement with Primum Pharma into the MEA Market
From DoseMe
Via Business Wire
DoseMe Fuels Global Expansion with Appointment of Siegfried Bräuer to Director International Sales
From DoseMe
Via Business Wire
DoseMe Announces 2023 Highlights; Precision Dosing Fast-Tracking to Top Trend in 2024
From DoseMe
Via Business Wire
DoseMe Amplifies Presence in Turkey via Distribution and Reseller Agreement with Primum Pharma
From DoseMe
Via Business Wire
UTMB Taps DoseMe’s Genetic Biomarker Capabilities for Precision Dosing
From DoseMe
Via Business Wire
DoseMe Adds Cefepime to Its Model-informed Precision Dosing Platform
From DoseMe
Via Business Wire
DoseMe Selected as a Pharma 2023 Innovation Award Winner
From DoseMe
Via Business Wire
Sarah Bush Lincoln Adopts DoseMe Precision Dosing Platform to Improve Overall Level of Patient Care
From DoseMe
Via Business Wire
A.C. Camargo Cancer Center Harnesses the Power of DoseMe Precision Dosing Platform to Substantially Reduce Toxicity and Kidney Injuries
From DoseMe
Via Business Wire
Clinical Webinar - From Theory to Practice: Maximizing Aminoglycoside Efficacy with the AUC-guided TDM
From DoseMe
Via Business Wire
DoseMe Achieves HITRUST Risk-based, 2-year Certification Demonstrating the Highest Level of Information Protection Assurance
From DoseMe
Via Business Wire
New England Life Care Selects DoseMe to Support New Initiatives Around Compliance Protocols
From DoseMe
Via Business Wire
DoseMe Expands Leadership Team with Appointments of Paul Edwards to CEO, John Hardesky to CCO and Sharmeen Roy to Chief Strategy & Science Officer
From DoseMe
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.